Accelerating discoveries for viral biology and host immunity with advanced cell analysis solutions

In the wake of global pandemics such as COVID-19, MERS-CoV, and Ebola, virology studies take center stage, capturing the attention of both scientists and the public alike. But within this “pathogen cloud” lies a silver lining—increased investment in viral biology research, the establishment of new scientific collaborations for rapid discovery, and renewed curiosity among the general public on the long-term health impact of emergent pathogens.